Kenneth C. Frazier, chairman and chief executive officer of Merck, sat down with Tony Coles, M.D., chairman and chief executive officer of Yumanity Therapeutics and chairman of Cerevel Therapeutics, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback